• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

确定骨肉瘤再入院和短期死亡率的可改变和不可改变风险因素:国家癌症数据库研究。

Identifying Modifiable and Non-modifiable Risk Factors of Readmission and Short-Term Mortality in Osteosarcoma: A National Cancer Database Study.

机构信息

Duke University School of Medicine, Durham, NC, USA.

Department of Orthopaedic Surgery, Duke University Hospital, Durham, NC, USA.

出版信息

Ann Surg Oncol. 2021 Nov;28(12):7961-7972. doi: 10.1245/s10434-021-10099-7. Epub 2021 May 20.

DOI:10.1245/s10434-021-10099-7
PMID:34018083
Abstract

BACKGROUND

There are limited data to inform risk of readmission and short-term mortality in musculoskeletal oncology. The goal of this study was to identify factors independently associated with 30-day readmission and 90-day mortality following surgical resection of osteosarcoma.

METHODS

We retrospectively reviewed patients (n = 5293) following surgical resection of primary osteosarcoma in the National Cancer Database (2004-2015). Univariate and multivariate methods were used to correlate variables with readmission and short-term mortality.

RESULTS

Of 210 readmissions (3.97%), risk factors independently associated with unplanned 30-day readmission included comorbidity burden (odds ratio [OR] 2.4, p = 0.042), Medicare insurance (OR 1.9, p = 0.021), and axial skeleton location (OR 1.5, p = 0.029). A total of 91 patients died within 90 days of their surgery (1.84%). Risk factors independently associated with mortality included age (hazard ratio 1.1, p < 0.001), increasing comorbidity burden (OR 6.6, p = 0.001), higher grade (OR 1.7, p = 0.007), increasing tumor size (OR 2.2, p = 0.03), metastatic disease at presentation (OR 8.5, p < 0.001), and amputation (OR 2.0, p = 0.04). Chemotherapy was associated with a decreased risk of short-term mortality (p < 0.001).

CONCLUSIONS

Several trends were clear: insurance status, tumor location and comorbidity burden were independently associated with readmission rates, while age, amputation, grade, tumor size, metastatic disease, and comorbidity burden were independently associated with short-term mortality.

摘要

背景

在肌肉骨骼肿瘤学中,有关再入院和短期死亡率的风险数据有限。本研究的目的是确定与骨肉瘤手术后 30 天再入院和 90 天死亡率相关的独立因素。

方法

我们回顾性地分析了国家癌症数据库(2004-2015 年)中接受骨肉瘤手术切除的 5293 名患者的数据。使用单变量和多变量方法将变量与再入院和短期死亡率相关联。

结果

210 例(3.97%)再入院中,与 30 天内非计划再入院独立相关的危险因素包括合并症负担(比值比 [OR] 2.4,p = 0.042)、医疗保险(OR 1.9,p = 0.021)和轴骨位置(OR 1.5,p = 0.029)。共有 91 例患者在手术后 90 天内死亡(1.84%)。与死亡率独立相关的危险因素包括年龄(风险比 1.1,p < 0.001)、合并症负担增加(OR 6.6,p = 0.001)、分级升高(OR 1.7,p = 0.007)、肿瘤大小增加(OR 2.2,p = 0.03)、初诊时存在转移疾病(OR 8.5,p < 0.001)和截肢(OR 2.0,p = 0.04)。化疗与短期死亡率降低相关(p < 0.001)。

结论

有几个趋势很明显:保险状况、肿瘤位置和合并症负担与再入院率独立相关,而年龄、截肢、分级、肿瘤大小、转移疾病和合并症负担与短期死亡率独立相关。

相似文献

1
Identifying Modifiable and Non-modifiable Risk Factors of Readmission and Short-Term Mortality in Osteosarcoma: A National Cancer Database Study.确定骨肉瘤再入院和短期死亡率的可改变和不可改变风险因素:国家癌症数据库研究。
Ann Surg Oncol. 2021 Nov;28(12):7961-7972. doi: 10.1245/s10434-021-10099-7. Epub 2021 May 20.
2
Identifying Modifiable and Non-modifiable Risk Factors of Readmission and Short-Term Mortality in Chondrosarcoma: A National Cancer Database Study.确定软骨肉瘤再入院和短期死亡率的可改变和不可改变的危险因素:国家癌症数据库研究。
Ann Surg Oncol. 2022 Feb;29(2):1392-1408. doi: 10.1245/s10434-021-10802-8. Epub 2021 Sep 27.
3
Six-month readmissions after bariatric surgery: Results of a nationwide analysis.减重手术后 6 个月的再入院率:一项全国性分析的结果。
Surgery. 2019 Nov;166(5):926-933. doi: 10.1016/j.surg.2019.06.003. Epub 2019 Aug 6.
4
Readmission following primary surgery for larynx and oropharynx cancer in the elderly.老年喉癌和口咽癌初次手术后的再入院情况。
Laryngoscope. 2017 Mar;127(3):631-641. doi: 10.1002/lary.26311. Epub 2016 Sep 23.
5
Independent Associations With 30- and 90-Day Unplanned Readmissions After Elective Lumbar Spine Surgery: A National Trend Analysis of 144 123 Patients.择期腰椎手术后 30 天和 90 天非计划性再入院的独立相关性:144123 例患者的全国趋势分析。
Neurosurgery. 2019 Mar 1;84(3):758-767. doi: 10.1093/neuros/nyy215.
6
Readmission after surgery for oropharyngeal cancer: An analysis of rates, causes, and risk factors.口咽癌手术后再入院:发生率、原因及危险因素分析
Laryngoscope. 2019 Apr;129(4):910-918. doi: 10.1002/lary.27461. Epub 2018 Sep 19.
7
National Landscape of Unplanned 30-Day Readmission Rates for Acute Non-hemorrhagic Diverticulitis: Insight from National Readmission Database.急性非出血性憩室炎 30 天再入院率的国家景观:来自国家再入院数据库的见解。
Dig Dis Sci. 2021 Apr;66(4):1009-1021. doi: 10.1007/s10620-020-06284-5. Epub 2020 May 1.
8
Temporal variability of readmission determinants in postoperative vascular surgery patients.术后血管外科患者再入院决定因素的时间变异性
J Postgrad Med. 2016 Oct-Dec;62(4):216-222. doi: 10.4103/0022-3859.188548.
9
Risk Factors Associated With Unplanned Readmission in Patients Undergoing Parotid Cancer Surgery: A Study of the National Cancer Database.与接受腮腺癌手术的患者非计划性再入院相关的风险因素:国家癌症数据库研究。
JAMA Otolaryngol Head Neck Surg. 2016 Jun 1;142(6):544-50. doi: 10.1001/jamaoto.2016.0216.
10
Unexpected readmission after lung cancer surgery: A benign event?肺癌手术后意外再次入院:是良性事件吗?
J Thorac Cardiovasc Surg. 2015 Dec;150(6):1496-1504, 1505.e1-5; discussion 1504-5. doi: 10.1016/j.jtcvs.2015.08.067. Epub 2015 Aug 28.

本文引用的文献

1
Application of nomograms to predict overall and cancer-specific survival in patients with chordoma.列线图在预测脊索瘤患者总生存和癌症特异性生存中的应用。
J Bone Oncol. 2019 Jun 24;18:100247. doi: 10.1016/j.jbo.2019.100247. eCollection 2019 Oct.
2
Survival analysis of patients with metastatic osteosarcoma: a Surveillance, Epidemiology, and End Results population-based study.转移性骨肉瘤患者的生存分析:一项监测、流行病学和最终结果的基于人群的研究。
Int Orthop. 2019 Aug;43(8):1983-1991. doi: 10.1007/s00264-019-04348-4. Epub 2019 May 24.
3
Soft Tissue Sarcoma of the Extremities: What Is the Value of Treating at High-volume Centers?
四肢软组织肉瘤:在高容量中心治疗的价值是什么?
Clin Orthop Relat Res. 2019 Apr;477(4):718-727. doi: 10.1097/01.blo.0000533623.60399.1b.
4
Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma.低容量医院的治疗与腹膜后肉瘤患者的短期和长期预后降低有关。
Cancer. 2018 Dec 1;124(23):4495-4503. doi: 10.1002/cncr.31699. Epub 2018 Oct 14.
5
Frailty and cancer: Implications for oncology surgery, medical oncology, and radiation oncology.虚弱与癌症:对肿瘤外科学、肿瘤内科和放射肿瘤学的影响。
CA Cancer J Clin. 2017 Sep;67(5):362-377. doi: 10.3322/caac.21406. Epub 2017 Jul 21.
6
Association of the Modified Frailty Index With 30-Day Surgical Readmission.改良虚弱指数与30天手术再入院的相关性
JAMA Surg. 2017 Aug 1;152(8):749-757. doi: 10.1001/jamasurg.2017.1025.
7
Using the National Cancer Database for Outcomes Research: A Review.利用国家癌症数据库进行结果研究:综述。
JAMA Oncol. 2017 Dec 1;3(12):1722-1728. doi: 10.1001/jamaoncol.2016.6905.
8
Unplanned 30-day hospital readmission as a quality measure in gynecologic oncology.非计划30天再入院作为妇科肿瘤学中的一项质量指标。
Gynecol Oncol. 2016 Dec;143(3):604-610. doi: 10.1016/j.ygyno.2016.09.020. Epub 2016 Sep 21.
9
Impact of Location of Readmission on Outcomes After Major Cancer Surgery.再次入院地点对重大癌症手术后结局的影响。
Ann Surg Oncol. 2017 Feb;24(2):319-329. doi: 10.1245/s10434-016-5528-1. Epub 2016 Sep 9.
10
Unplanned 30-day readmissions in orthopaedic trauma.骨科创伤患者的非计划30天再入院情况。
Injury. 2016 Aug;47(8):1794-7. doi: 10.1016/j.injury.2016.05.007. Epub 2016 May 14.